STOCK TITAN
  1. Home
  2. News
  3. OWLT

Owlet, Inc. - OWLT STOCK NEWS

Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.

Owlet, Inc. (NYSE: OWLT) is revolutionizing the digital parenting landscape by providing innovative solutions that bring peace of mind to parents. The company has developed a comprehensive digital platform that delivers real-time data and insights to help parents feel more calm and confident in their parenting journey. Its standout product, the Owlet Smart Sock, is the first baby monitor designed to track an infant's oxygen levels, heart rate, and sleep trends, providing critical information to ensure the well-being of newborns.

The Owlet Cam complements the Smart Sock, transforming any smartphone into a high-definition baby monitor. This combination is taken further with the Owlet Monitor Duo, which integrates the functionalities of both the Smart Sock and the Cam, offering a holistic monitoring solution. Additionally, Owlet offers the Owlet Dream Lab, an interactive program that helps parents establish healthy sleep habits for their infants through expert guidance and personalized plans.

In recent news, Owlet has announced a strategic partnership with Wheel, a leading virtual care platform. This collaboration will enhance Owlet’s offerings by providing caregivers with timely prescriptions for BabySat™, Owlet's FDA-cleared pulse oximeter for infants with pre-existing medical conditions. This integration with Wheel's extensive clinical network and infrastructure will significantly improve access to critical in-home monitoring services.

Owlet's financial condition remains robust as it continues to innovate and expand its product portfolio. The partnerships with leading healthcare providers and insurance companies further strengthen its market position by offering up to 100% reimbursement for BabySat through insurance or HSA/FSA programs.

Owlet’s vision of empowering parents with cutting-edge technology is reflected in their continuous efforts to integrate advanced features and seek strategic partnerships. Their commitment to improving infant care and parental confidence encapsulates their mission to transform the future of digital parenting.

News

Owlet Achieves De Novo FDA-Clearance For Dream Sock® – The First and Only Over-the-Counter, Medical Grade Pulse Oximeter Cleared for Infants

Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) announces FDA De Novo clearance for Dream Sock, the first over-the-counter medical pulse oximetry solution for infants. The cleared features include monitoring and displaying Baby’s Live Health Readings, pulse rate, and oxygen saturation level, and providing Health Notifications. This sets new standards in at-home infant care, providing enhanced peace of mind for parents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
none
-
News

Owlet to Report Third Quarter 2023 Financial Results on November 13, 2023

Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) will release its Q3 2023 results on November 13, 2023. The earnings release will be available on Business Wire and Owlet's Investor Relations website. A conference call will be hosted by CEO Kurt Workman and CFO Kate Scolnick at 4:30 p.m. ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences earnings
-
News

Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

Rhea-AI Summary
Owlet partners with Dr. Harrington and Knox Blocks Foundation to raise funds for SIDS research, aiming to identify biomarkers and develop preventative screenings. SIDS claims over 3,000 babies' lives annually in the US. Owlet donates 5% of global sales in October to the project. Owlet also supports parents through various initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
News

Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors

Rhea-AI Summary
Owlet, Inc. announces the appointment of Marc Stoll to its Board of Directors. Stoll brings over 25 years of experience in finance and technology industries and will help bolster Owlet's future ventures and growth potential. He has expertise in corporate strategy and operational excellence. Stoll's appointment will accelerate the company's global growth strategies in consumer and medical product distribution channels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.48%
Tags
management
-
News

Owlet Announces Second Quarter 2023 Financial Results

Rhea-AI Summary
Owlet reports Q2 2023 financial results, with revenues of $13.1 million, a 22% increase from Q1 2023. Operating expenses declined 21% to $11.9 million. Gross margin improved to 40% from 36.1% in Q2 2022. The company received FDA clearance for BabySat™, its pulse-oximetry device, and remains on track with the de novo submission for Health Notifications software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.42%
Tags
earnings
-
News

Owlet to Report Second Quarter 2023 Financial Results on August 14, 2023

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
conferences earnings
News

Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

Rhea-AI Summary
Owlet, Inc. announces the appointment of Jonathan Harris as its new President and Chief Revenue Officer. Harris has over 30 years of experience and a proven track record in leading go-to-market strategies for top brands. He joins Owlet after the FDA clearance of BabySat™, the first medical pulse-oximetry device with Owlet's wire-free sock design. Harris will work with the executive team to accelerate go-to-market strategies and expand both consumer and medical product lines.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News

Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
management
-
News

Owlet, Inc. Announces NYSE Acceptance of Continued Listing Compliance Plan

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.77%
Tags
none
News

Owlet, Inc. Announces 1-For-14 Reverse Stock Split Will Become Effective

Rhea-AI Summary
Owlet, Inc. announces a 1-for-14 reverse stock split of its Class A common stock, which will become effective on July 10, 2023. The split is expected to help the company regain compliance with the NYSE's minimum average closing price requirement. The number of issued and outstanding shares will be reduced from approximately 118,078,000 to approximately 8,434,142.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.21%
Tags
none

FAQ

What is the current stock price of Owlet (OWLT)?

The current stock price of Owlet (OWLT) is $4.64 as of December 20, 2024.

What is the market cap of Owlet (OWLT)?

The market cap of Owlet (OWLT) is approximately 73.4M.

What is Owlet, Inc. known for?

Owlet, Inc. is known for its digital parenting platform, providing real-time data and insights to help parents monitor their infants' health.

What products does Owlet offer?

Owlet offers products like the Smart Sock, Owlet Cam, Monitor Duo, and Dream Lab, all designed to help parents monitor and care for their infants.

What is the Owlet Smart Sock?

The Smart Sock is a baby monitor that tracks an infant's oxygen levels, heart rate, and sleep trends, providing parents with critical health information.

How does the Owlet Cam work?

The Owlet Cam transforms any smartphone into a high-definition baby monitor, offering clear and reliable video monitoring of the infant.

What is the Owlet Monitor Duo?

The Monitor Duo combines the functionalities of the Smart Sock and Owlet Cam to provide comprehensive monitoring of an infant's health and environment.

What is the purpose of the Owlet Dream Lab?

The Dream Lab is an interactive program that guides parents in building healthy sleep habits for their infants through expert advice and personalized plans.

Who is Owlet's latest strategic partner?

Owlet’s latest strategic partner is Wheel, a virtual care platform that will help provide timely prescriptions for BabySat and enhance in-home monitoring services.

What is BabySat?

BabySat is Owlet's FDA-cleared pulse oximeter designed for infants with pre-existing medical conditions, allowing for effective health monitoring.

What financial benefits do parents get from Owlet products?

Owlet products like BabySat can offer up to 100% reimbursement through insurance or HSA/FSA programs, making them more accessible to parents.

How does Owlet contribute to the future of digital parenting?

Owlet contributes to the future of digital parenting by continuously innovating and integrating advanced technology to improve infant care and parental confidence.

Stock OWLT logo
Owlet, Inc.

NYSE:OWLT

OWLT Rankings

#4634 Ranked by Market Cap
N/A Ranked by Dividends

OWLT Stock Data

73.45M
14.30M
8.76%
46.64%
2.14%
Health Information Services
Measuring & Controlling Devices, Nec
Link
United States of America
LEHI